1.7 billion people. One coordination failure.
Musculoskeletal conditions are the single largest contributor to disability worldwide — roughly one in six of all years lived with disability. The burden falls hardest on less research-intensive regions of Europe, many of them COST Inclusiveness Target Countries that carry the highest rates while remaining least connected to the field’s emerging science.
A new generation of regenerative therapies is advancing fast — but the field is fragmented and inconsistently defined, with no shared classification, no agreed outcome standard, no European quality benchmark and no coordinated training route. Evidence cannot be pooled, effort is duplicated, and unproven treatments compete on equal footing with evidence-based ones. This is a coordination failure no single research project can solve.
Preserve. Repair. Regenerate. Before replace.
Repair and regeneration are points on the same biological continuum: repair restores the integrity of injured tissue; regeneration restores its structure and function. The body does both remarkably well — a marathon runner’s calf recovers in 24–48 hours — but when degeneration outpaces healing, replacement becomes the default. IAMRegen’s ambition is to shift the balance of care up the pathway, so stimulating the body’s own capacity reduces the need to replace the joint.
Eight objectives. Two engines.
The barrier is coordination, not discovery.
The knowledge, techniques and expert groups already exist across Europe. What is missing is a shared framework, comparable evidence, agreed standards and a route for people and knowledge to move between centres — networking problems by definition. A pan-European COST Action funds exactly this: consensus, common standards, training, mobility and dissemination.
COST funds the networking, not the research — so partners join and benefit at no research cost to their institution. The consortium is built to COST eligibility: at least seven COST Full or Cooperating Members, at least half from Inclusiveness Target Countries, and at least 40% Young Researchers and Innovators.
Five meetings, one growing Action.
From a founding meeting at the Royal Society of Medicine to an international association — Torino 2027 is our fifth annual meeting.




About I AM Regen.
What is I AM Regen?
I AM Regen is the International Association of Musculoskeletal Regeneration — an international professional programme operated by MSK REGEN (registered charity no. 1211400, England and Wales). It is professionally informed and trustee-governed, and brings clinicians, scientists and centres together to develop transparent standards, consensus and education for musculoskeletal regeneration.
Read more about I AM Regen →Who leads the International Association of Musculoskeletal Regeneration?
I AM Regen is a programme of the charity MSK REGEN; its trustees hold ultimate governance. The programme is led by an executive team: a President (Professor Paul Lee), a President-Elect who also chairs the Scientific Advisory Board (Professor Feza Korkusuz), a Vice-President (Professor Luminita Labusca), a Congress President and Education Vice-President (Professor Riccardo Ferracini) and a Research & Grants Vice-President who co-chairs the Scientific Advisory Board (Professor Victoria Sarafian). These are programme appointments; Members and Fellows do not have a governance vote.
Meet the executive team →What is the difference between an I AM Regen Member and a Fellow?
Members join the programme by application. Fellow is a recognition of standing and contribution, by application and invitation — the honour is not purchasable. Fellows can host visiting fellowships and lead I AM Regen Centres of Excellence. Member membership is €100/year and includes Congress registration, subject to capacity and event rules; the Fellow service tier is €150/year.
Compare Member & Fellow →How do I join I AM Regen?
Apply and pay online as a Member for €100/year (Student €50/year with current-enrolment evidence). Membership includes Congress registration, subject to capacity and event rules, and makes you eligible to take part in the consensus process. Membership does not buy authorship or a governance vote.
Join I AM Regen →What is an I AM Regen Centre of Excellence?
An I AM Regen Centre of Excellence is a clinic or laboratory recognised by IAMRegen under a published standard for regenerative practice or science. Recognition is voluntary and time-limited — it is not a licence to practise, regulatory approval or a certification of every practitioner or treatment.
Explore Centres of Excellence →When and where is the next I AM Regen Congress?
The 5th IAMRegen International Congress takes place on Friday 12 February 2027 at the Accademia di Medicina in Torino, Italy, in person only. It is the fifth meeting in the continuing MSK Regen–IAMRegen series and the first held under the IAMRegen name.
See the Torino 2027 Congress →What is the I AM Regen consensus (Delphi) process?
IAMRegen develops consensus through two anonymous online Delphi rounds with published thresholds, ratified at the in-person Congress. The first IAMRegen consensus programme is in development and no annual consensus has yet been published. Completing both rounds and attending the Congress qualifies a participant for collaborator recognition — authorship is separate and contribution-based.
About the consensus process →What is the I AM Regen Travelling Fellowship?
The I AM Regen Travelling Fellowship connects the network lab to lab and clinic to clinic: a Fellow hosts at their I AM Regen Centre of Excellence and Members apply to visit, learn and collaborate.
About the Travelling Fellowship →

